Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canntab Therapeutics Ltd C.PILL


Primary Symbol: CTABF

Canntab Therapeutics Limited is a Canadian phytopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The Company’s operations comprise a single segment engaged in the medical marijuana business. The Company’s hard pill cannabinoid formulations provide doctors, patients, and consumers with medical grade solutions. These include once a day and extended-release formulations. Its products include INSTANT RELEASE - (IR Tablet), EXTENDED-RELEASE - (XR Tablet), and ORAL DISSOLVING - O.D. Tablet (ODT). The IR Tablet is a release profile for solid hard tablets. The XR Tablet is a phytocannabinoid vehicle that is designed to directly address the drawbacks and challenges of competing oral delivery systems. ODT is specifically designed to dissolve directly in the patient’s mouth, with an onset of action between five and thirty minutes.


GREY:CTABF - Post by User

Canntab Therapeutics Ltd > Re TFSA SPIN OFFS
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(8)
•••
Comment by Tonydeon Mar 28, 2019 9:44pm
148 Views
Post# 29551771

RE:RE:Re TFSA SPIN OFFS

RE:RE:Re TFSA SPIN OFFS
Everyone that owned Telferscot (TFS) shares last year should have received a letter from their broker stating that the SpinCos (numbered corporation) were Non Qualified Investment (NQI) for any Registered Account, and investors were given three (3 ) options (by Law), one of them to move them into a cash account. Now that one of them is listed, CB2 Insights Inc. (CBII), this security can be moved back to any Registered Account. The other six should remain in a cash account until the day they are listed on an exchange. By now CBII shares should show into your account stating the number of shares (at the ratio of 16.5 old shares for 1 New Share) and the value ($). By the way, our Cost was 16.5 cents per CBII share. In regards of TD will not accept your instructions, if it was me, I will transfer my securities to another broker. I don't mean to sound rude, however it's my hard earned money. Hope that this will shed some light. GLTA.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities